Seattle Cancer Care Alliance (SCCA) experts offer comprehensive melanoma care at the Multidisciplinary Skin Oncology Clinic, including advanced treatments and new options available only through clinical studies.
A diagnosis of cancer can feel overwhelming. We have an experienced, compassionate team ready to help.
- Expertise at SCCA
- Targeted therapy
- Radiation therapy
- Clinical trials
- Next steps
Melanoma expertise at SCCA
Everything you need is here
We have dermatologists, surgeons, medical oncologists and radiation oncologists who specialize in melanoma. As a member institution of the National Comprehensive Cancer Network, SCCA is home to doctors who help define the national standards for melanoma care.
Innovative melanoma therapies
SCCA patients have access to advanced therapies being explored in clinical studies for melanoma conducted here and at our founding organizations Fred Hutchinson Cancer Research Center and UW Medicine.
Melanoma treatment tailored to you
We view treatment as a collaborative effort. Your SCCA doctors will explain all your options and recommend a treatment plan based on the type, location, size and stage of your cancer and your overall health.
Your personal team includes more than your melanoma doctors. Additional experts who specialize in treating people with cancer will be involved if you need them — experts like a palliative care professional, social worker, physical therapist, dietitian or integrative medicine provider.
Ongoing care and support
During and after treatment, your team continues to provide follow-up care on a schedule tailored to you. The SCCA Survivorship Clinic is also here to help you live your healthiest life as a melanoma survivor.
Surgery for melanoma
Surgery is usually the main treatment for melanoma. Often this means your primary care doctor or dermatologist removes suspicious tissue, and has it checked for cancer (biopsied), before you ever see a specialist at SCCA. If your tumor is removed very early, you may not need any other treatment.
If your melanoma is localized, meaning it is just on your skin, you may need only a simple excision (removing it by cutting it out).
- Your doctor removes the tumor, along with a margin of normal-looking skin around the tumor. If the melanoma is thicker, your surgeon will have to cut wider margins. This is important so that the melanoma does not grow back at the original location later.
- If the doctor did not take wide margins during your original biopsy, you may need another excision to remove more skin, including very small lymph vessels near the tumor where cancer cells might have spread.
- Depending on where your melanoma is and how large the margins need to be, you might need only a local numbing medicine or you might have general anesthesia.
SCCA melanoma surgeons and plastic surgeons coordinate to treat tumors in sensitive locations, like the face or hand.
Sentinel lymph node mapping and biopsy
Thicker melanomas tend to spread to nearby lymph nodes, which need to be checked for cancer and possibly removed.
A tracer substance and a dye are injected near your tumor to find the lymph node or nodes where your cancer would spread first (sentinel nodes). Your surgeon removes only the nodes where the substance appears, and a pathologist checks the nodes for cancer cells.
- If cancer is found, your surgeon removes the lymph nodes in that area.
- If cancer is not found, the rest of your lymph nodes will be left in place.
SCCA's David R. Byrd, MD, brought this technique, sentinel lymph node mapping and biopsy, to the Northwest in the 1990s.
Learn more about surgical oncology.
Preventing and treating lymphedema
Lymphedema is not common, but it is a possible complication. So after any lymph node surgery, we refer our patients to physical therapists (PTs) with expertise in preventing, detecting and managing lymphedema.
We have several resources for lymphedema treatment, including PTs who provide complete decongestive therapy and specialized reconstructive surgeons who offer advanced surgical treatments, such as lymph vessel reconnection surgery and lymph-node transfer.
Immunotherapy for melanoma
Immunotherapies harness your body’s immune system to fight your cancer. One type is called an immune checkpoint inhibitor. These medicines block proteins that normally keep your immune cells in check so that they do not become overactive.
Immune checkpoint inhibitors used for melanoma include:
- Pembrolizumab (Keytruda) and nivolumab (Opdivo) — These block the protein PD-1, taking the brakes off your T cells and allowing these immune cells to attack your cancer.
- Ipilimumab (Yervoy) — This medicine targets a different protein, CTLA-4. It is sometimes used in combination with pembrolizumab or nivolumab.
Other types of immunotherapy for melanoma include:
- T-VEC therapy — This is a genetically engineered virus that is injected into melanoma tumors. The virus kills the melanoma cells and triggers an immune response that helps in the clearance of cancer cells. T-VEC is also known as talimogene laherparepvec or Imlygic.
- Imiquimod (Aldara) — This is a cream you rub on your skin.
Learn more about immunotherapy.
Targeted therapy for melanoma
Targeted therapies work selectively against cancer cells, rather than affecting all fast-growing cells, like standard chemotherapy does). Many of them target a gene or protein responsible for allowing cancer to grow.
Target therapies for melanoma include:
- BRAF inhibitors — Medicines that block the BRAF protein, such as vemurafenib (Zelboraf), dabrafenib (Tafinlar) and encorafenib (Braftovi).
- MEK inhibitors — Medicines that block the MEK protein, such as trametinib (Mekinist), cobimetinib (Cotellic) and binimetinib (Mektovi)
Your SCCA team will talk with you about the specific immunotherapies or targeted therapies we recommend for you, how you’ll receive them, your treatment schedule and what to expect. We’ll also explain how to take the best possible care of yourself during treatment and after, and we’ll connect you with medical and support resources throughout SCCA.
Learn more about targeted therapies in our medical oncology section.
Radiation therapy for melanoma
Radiation therapy is often given to people with melanoma:
- After surgery to decrease the odds of cancer returning
- To prevent or relieve symptoms if cancer has spread to multiple parts of the body, especially the brain or bones
Radiation therapy is painless and noninvasive (similar to getting a CT scan), and each treatment lasts only minutes. Different types of radiation therapy are used for different situations. A few examples are described below.
Radiosurgery is an advanced form of highly focused, high-dose radiation therapy that can kill tumors in fewer treatments than conventional radiation treatment — typically one to five session rather than daily sessions for several weeks. It has a greater than 95 percent chance of killing small tumors.
There are many names for this type of treatment, including:
- Stereotactic body radiation therapy (SBRT)
- Stereotactic ablative body radiotherapy (SABR)
- CyberKnife or GammaKnife, brand names
Gamma Knife is specifically designed for treating tumors in the brain. It is not a knife or scalpel in the usual sense of the word (neither is CyberKnife), and it doesn’t require opening the skull. Instead, it uses precisely focused beams of radiation. Patients are usually treated in one session.
Intensity-modulated image-guided radiotherapy (IMRT/IGRT)
In this form of radiation treatment, doctors use computed tomography (CT) to scan your tumor and create beams of radiation that closely conform to the tumor's shape. The beams vary in shape and intensity to deliver a higher dose of radiation to the tumor and lower doses to nearby healthy tissue.
IMRT/IGRT is generally used after surgery if there’s a high risk the cancer might recur, such as if multiple lymph nodes in the neck are involved.
Neutron therapy is a strong form of radiotherapy used for advanced melanomas that cannot be removed by surgery. It also helps with pain and other symptoms when melanoma is widespread.
Learn more in our radiation oncology section.
Clinical trials for melanoma
Melanoma treatment has advanced dramatically in the past decade, allowing more patients to live longer, free of any signs or symptoms of the disease. Still, today’s options do not work as well as we want for every person, and we are actively pursuing more effective therapies.
For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at SCCA and our founding organizations Fred Hutch and UW Medicine is often the main reason many patients come to SCCA. We have a wide variety of clinical studies for melanoma, including studies of vaccines, immune cell treatments and other immunotherapies.
Our doctors are working toward being able to stage and characterize melanoma down to the molecular level. Defining the genetic changes that cause different types of melanoma will help us identify patients whose disease may respond better to more customized regimens.